[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100568261":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":110,"collaborators":7,"id":112,"slug":113,"hasResults":114,"nctId":115,"briefTitle":116,"officialTitle":116,"acronym":7,"eligibilityCriteria":117,"healthyVolunteers":114,"sex":118,"minAge":119,"maxAge":7,"enrollmentInfo":120,"targetDuration":123,"studyType":124,"phases":7,"briefSummary":125,"conditions":126,"keywords":128,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":130,"lastUpdatePostDateStruct":131,"startDateStruct":134,"completionDateStruct":136,"leadSponsor":138,"locationsCount":139},{"fullName":5,"class":6},"Arbeitsgemeinschaft medikamentoese Tumortherapie","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Daniela Wolkersdorfer, Dr.","CONTACT","+436626404412","office@agmt.at",[15,32,41,53,74,86,98],{"facility":16,"status":17,"city":18,"state":7,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"Ordensklinikum Linz, BHS - Interne I","RECRUITING","Linz","4010","Austria","AT",{"type":23,"coordinates":24},"Point",[25,26],14.28611,48.30639,{"lat":26,"lon":25},[29],{"name":30,"role":31,"phone":7,"phoneExt":7,"email":7},"Holger Rumpold, MD","PRINCIPAL_INVESTIGATOR",{"facility":33,"status":17,"city":18,"state":7,"zip":34,"country":20,"countryCode":21,"cosmosGeoPoint":35,"geoPoint":37,"contacts":38},"KUK Linz - Med Campus III.: Univ.-Klinik für Hämatologie und Internistische Onkologie","4021",{"type":23,"coordinates":36},[25,26],{"lat":26,"lon":25},[39],{"name":40,"role":31,"phone":7,"phoneExt":7,"email":7},"Clemens Schmitt, MD",{"facility":42,"status":17,"city":43,"state":7,"zip":44,"country":20,"countryCode":21,"cosmosGeoPoint":45,"geoPoint":49,"contacts":50},"LKH Feldkirch: Innere Medizin II\u002F Interne E (Hämatologie und Onkologie)","Rankweil","6830",{"type":23,"coordinates":46},[47,48],9.64308,47.27108,{"lat":48,"lon":47},[51],{"name":52,"role":31,"phone":7,"phoneExt":7,"email":7},"Thomas Winder, MD",{"facility":54,"status":17,"city":55,"state":7,"zip":56,"country":20,"countryCode":21,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"Department of Internal Medicine III, Paracelsus Medical University Salzburg","Salzburg","5020",{"type":23,"coordinates":58},[59,60],13.04399,47.79941,{"lat":60,"lon":59},[63,67,69,72],{"name":64,"role":11,"phone":65,"phoneExt":7,"email":66},"Florian Huemer, Priv.Doz. Dr","+435725557082","f.huemer@salk.at",{"name":68,"role":31,"phone":7,"phoneExt":7,"email":7},"Florian Huemer, Priv. Doz. Dr.",{"name":70,"role":71,"phone":7,"phoneExt":7,"email":7},"Lukas Weiss, Priv. Doz. Dr. med. univ.","SUB_INVESTIGATOR",{"name":73,"role":71,"phone":7,"phoneExt":7,"email":7},"Konstantin Schlick, Priv.-Doz. Dr.",{"facility":75,"status":17,"city":76,"state":7,"zip":77,"country":20,"countryCode":21,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"Klinikum Steyr: Innere Medizin II: Onkologie, Gastroenterologie, Angiologie","Steyr","4400",{"type":23,"coordinates":79},[80,81],14.42127,48.04274,{"lat":81,"lon":80},[84],{"name":85,"role":31,"phone":7,"phoneExt":7,"email":7},"Georg Schreil, MD",{"facility":87,"status":17,"city":88,"state":7,"zip":89,"country":20,"countryCode":21,"cosmosGeoPoint":90,"geoPoint":94,"contacts":95},"Klinikum Wels: Abteilung für Innere Medizin IV","Wels","4600",{"type":23,"coordinates":91},[92,93],14.03333,48.16667,{"lat":93,"lon":92},[96],{"name":97,"role":31,"phone":7,"phoneExt":7,"email":7},"Sonja Heibl, MD",{"facility":99,"status":17,"city":100,"state":7,"zip":101,"country":20,"countryCode":21,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"KH Zams: Innere Medizin Internistische Onkologie und Hämatologie","Zams","6511",{"type":23,"coordinates":103},[104,105],10.5897,47.15844,{"lat":105,"lon":104},[108],{"name":109,"role":31,"phone":7,"phoneExt":7,"email":7},"Ewald Wöll, MD",{"type":111,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100568261","agmt-metastatic-colorectal-cancer-registry-mcrc-third-line-and-beyond-100568261",false,"NCT06678919","AGMT Metastatic Colorectal Cancer Registry (mCRC) Third Line and Beyond","Inclusion Criteria:\n\n* patients ≥ 18 years with tissue-based diagnosis of mCRC\n* ≥ 2 prior lines of palliative systemic therapy including 5-FU, irinotecan, oxaliplatin, anti-VEGF, anti-EGFR (in case of RAS\u002FBRAF wildtype), anti-PD1- therapy (in case of MSI\u002FMMRd) . (Exception: Patients who have received mFOLFOXIRI +\u002F- anti-VEGF or anti- EGFR- 1L therapy or patients with ineligibility to receive 5-FU, oxaliplatin or irinotecan can be included after 1st line.)\n\nExclusion Criteria:\n\n* Due to the non-interventional design of this registry, there are no specific exclusion criteria","ALL","18 Years",{"count":121,"type":122},500,"ESTIMATED","10 Years","OBSERVATIONAL","Colorectal cancer (CRC) is the second leading cause of cancer-related death in the United States and Europe. Although selected patients with oligometastatic CRC undergo systemic therapy and surgery\u002Flocal ablative therapy in curative intent, the treatment approach for the majority of metastatic CRC (mCRC) patients remains palliative with a median overall survival (OS) ranging between 9-38 months depending on various prognostic and predictive factors. Particularly in advanced stages (in the third line of therapy and beyond), interesting and promising results have recently been achieved with various treatment approaches. The aim of this registry is to establish a disease-specific registry to evaluate the treatment landscape of patients with mCRC who have already received at least two lines of therapy.",[127],"Metastatic Colorectal Cancer (mCRC)",[129],"colorectal","2025-04-09",{"date":132,"type":133},"2025-04-10","ACTUAL",{"date":135,"type":133},"2024-10-31",{"date":137,"type":122},"2034-12",{"name":5,"class":6},7]